Literature DB >> 3242576

Initial blood pressure as a predictor of the response to antihypertensive therapy.

D J Sumner1, P A Meredith, C A Howie, H L Elliott.   

Abstract

1. The relationship between fall in systolic blood pressure and initial systolic blood pressure has been investigated in 255 mixed normotensive and hypertensive subjects given placebo or one of five types of antihypertensive drug (ACE inhibitors, calcium antagonists, direct vasodilators, alpha-adrenoceptor blocker, beta-adrenoceptor blocker). 2. In all cases there was a significant correlation between the change in blood pressure and initial blood pressure. When Oldham's transformation was used (replacing the initial blood pressure by the mean of the initial and minimum pressures) the correlation coefficients were all reduced, although five out of six were still statistically significant. 3. In a subset of 43 hypertensive subjects given four antihypertensive agents, concentration-effect analysis was carried out. For three of the agents a linear model was used to relate effect to concentration; for the remaining agent a Langmuir type model was used. 4. For all four sets of data for which concentration-effect analysis was carried out, there was a significant correlation between the sensitivity of response and the initial blood pressure. 5. The observed relationships between initial blood pressure, change in blood pressure and sensitivity of response can be qualitatively explained by postulating a general form of dose-response relationship for all antihypertensive agents.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3242576      PMCID: PMC1386586          DOI: 10.1111/j.1365-2125.1988.tb05310.x

Source DB:  PubMed          Journal:  Br J Clin Pharmacol        ISSN: 0306-5251            Impact factor:   4.335


  6 in total

1.  A note on the analysis of repeated measurements of the same subjects.

Authors:  P D OLDHAM
Journal:  J Chronic Dis       Date:  1962-10

2.  Misleading paper about misleading statistics.

Authors: 
Journal:  Lancet       Date:  1985-04-20       Impact factor: 79.321

3.  Relation between initial blood pressure and its fall with treatment.

Authors:  J S Gill; A V Zezulka; D G Beevers; P Davies
Journal:  Lancet       Date:  1985-03-09       Impact factor: 79.321

4.  Simultaneous modeling of pharmacokinetics and pharmacodynamics: application to d-tubocurarine.

Authors:  L B Sheiner; D R Stanski; S Vozeh; R D Miller; J Ham
Journal:  Clin Pharmacol Ther       Date:  1979-03       Impact factor: 6.875

5.  Does nifedipine reveal a functional abnormality of arteriolar smooth muscle cell in essential hypertension--the effect of altering sodium balance.

Authors:  G A MacGregor; N D Markandu; S J Smith; G A Sagnella
Journal:  J Cardiovasc Pharmacol       Date:  1985       Impact factor: 3.105

6.  Contrasting effects of nifedipine, captopril, and propranolol in normotensive and hypertensive subjects.

Authors:  G A MacGregor; C Rotellar; N D Markandu; S J Smith; G A Sagnella
Journal:  J Cardiovasc Pharmacol       Date:  1982       Impact factor: 3.105

  6 in total
  10 in total

Review 1.  Use of gene markers to guide antihypertensive therapy.

Authors:  S T Turner; G L Schwartz; A B Chapman; E Boerwinkle
Journal:  Curr Hypertens Rep       Date:  2001-10       Impact factor: 5.369

2.  A comparison of the haemodynamic and behavioural effects of moxonidine and clonidine in normotensive subjects.

Authors:  G J Macphee; C A Howie; H L Elliott; J L Reid
Journal:  Br J Clin Pharmacol       Date:  1992-03       Impact factor: 4.335

3.  The description and prediction of antihypertensive drug response: an individualised approach.

Authors:  R Donnelly; P A Meredith; H L Elliott
Journal:  Br J Clin Pharmacol       Date:  1991-06       Impact factor: 4.335

Review 4.  Pharmacokinetic-pharmacodynamic relationships of alpha-adrenoceptor antagonists.

Authors:  R Donnelly; P A Meredith; H L Elliott
Journal:  Clin Pharmacokinet       Date:  1989-10       Impact factor: 6.447

Review 5.  Concentration-effect analysis of antihypertensive drug response. Focus on calcium antagonists.

Authors:  R Donnelly; H L Elliott; P A Meredith
Journal:  Clin Pharmacokinet       Date:  1994-06       Impact factor: 6.447

6.  Concentration-effect relationships and individual responses to doxazosin in essential hypertension.

Authors:  R Donnelly; H L Elliott; P A Meredith; J L Reid
Journal:  Br J Clin Pharmacol       Date:  1989-11       Impact factor: 4.335

7.  The effects of age on the pharmacokinetics, antihypertensive efficacy and general tolerability of dilevalol.

Authors:  G J Macphee; C A Howie; P A Meredith; H L Elliott
Journal:  Br J Clin Pharmacol       Date:  1991-11       Impact factor: 4.335

8.  Serum concentration-effect relationship of (+/-)-nicardipine and nifedipine in elderly hypertensive patients.

Authors:  H C Porchet; F Loew; L Gauthey; P Dayer
Journal:  Eur J Clin Pharmacol       Date:  1992       Impact factor: 2.953

9.  Influence of input rates on (+/-)-isradipine haemodynamics and concentration-effect relationship in healthy volunteers.

Authors:  V Carrara; H Porchet; P Dayer
Journal:  Eur J Clin Pharmacol       Date:  1994       Impact factor: 2.953

10.  Effect of a cheese rich in angiotensin-converting enzyme-inhibiting peptides (Gamalost(®)) and a Gouda-type cheese on blood pressure: results of a randomised trial.

Authors:  Rita Nilsen; Are H Pripp; Arne T Høstmark; Anna Haug; Siv Skeie
Journal:  Food Nutr Res       Date:  2016-08-04       Impact factor: 3.894

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.